Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01638897 · ClinicalTrials.gov registry record
DF4 Connector System Post-Approval Study
A clinical trial, sponsored by Medtronic.
- Completed
- Registry status
- 1,778
- Enrollment target
NCT01638897 is a clinical trial that has completed, run by Medtronic. The registered enrollment target is 1,778 participants.
The verdict
NCT01638897 has completed, sponsored by Medtronic.
- COMPLETED
- Registry status
- 1,778 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate long-term performance of the DF4 Connector System. This evaluation is based on the number of DF4 lead-related complications occurring during the study compared to the number of leads enrolled in the study. The DF4 systems will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the DF4 Connector Systems. This study is conducted within Medtronic's post-market surveillance platform.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,778 participants |
| Start Date | 2012-01 |
| Est. Completion | 2019-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01638897
The ClinicalTrials.gov registry entry for NCT01638897 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,778 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01638897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01638897 about?
NCT01638897 is a clinical study titled "DF4 Connector System Post-Approval Study". The purpose of this study is to evaluate long-term performance of the DF4 Connector System. This evaluation is based on the number of DF4 lead-related complications occurring during the study compared to the number of leads enrolled in the study. The DF4 systems will be followed for 5 years after im...
What is the current status of trial NCT01638897?
This trial is currently completed. The enrollment target is 1,778 participants. The study started on 2012-01. Estimated completion is 2019-03.
Who is sponsoring clinical trial NCT01638897?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.